检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Treatment efficacy in patients with moderate-to-severe atopic dermatitis who switched from dupilumab to abrocitinib in JADE EXTEND, a phase 3 long-term extension study

Melinda J. Gooderham,Stephan Weidinger,Eric L. Simpson,Mette Deleuran,Linda F. Stein Gold,Saleem A. Farooqui,Pinaki Biswas,Gary Chan,Erman Guler,Herwig Koppensteiner

BRITISH JOURNAL OF DERMATOLOGY（2024）

引用 0|浏览1
暂无评分
关键词
abrocitinib,atopic dermatitis,dupilumab,Janus kinase inhibitor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要